How is the Immunovant Inc today?

The Immunovant Inc today is trading in the down by -1.77% at 16.10.

How has Immunovant Inc performed historically?

The Immunovant Inc is currently trading down -1.77% on an intraday basis in the past week the index rose 1.51%. The index has been down -10.01% in the past quarter and fell -38.22% in the past year. You can view this in the overview section.

What is Immunovant Inc Annual Net Profit?

Immunovant Inc Annual Net Profit fell 59.58% in the last year to $413.84 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Immunovant Inc Price to Earning Ratio?

Immunovant Inc Price to Earning Ratio is -6.65, which is negative.

What is Immunovant Inc Stock Price?

Immunovant Inc Stock Price fell 38.22% and underperformed its sector by 73.09% in the past year.

What is Immunovant Inc Quarterly Net profit?

Immunovant Inc Quarterly Net profit fell 41.33% YoY to $106.45 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is Immunovant Inc Debt to Equity Ratio?

Immunovant Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Immunovant Inc Return on Equity(ROE)?

Immunovant Inc Return on Equity(ROE) for the last financial year was -62.46%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Immunovant Inc Mutual Fund Holding?

Immunovant Inc Mutual Fund Holding increased by 0.54% in the last quarter to 31.99.

What is Immunovant Inc Promoter Share Holding?

Immunovant Inc Promoter Share Holding decreased by 1.25% in the most recent quarter to 5.54%.

What is Immunovant Inc Institutional Holding?

Immunovant Inc Institutional Holding increased by 7.57% in the last quarter to 56.99.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
IMMUNOVANT INC

Immunovant Inc XNAS: IMVT

Immunovant Inc Live Share Price Today, Share Analysis and Chart

Name: Immunovant Inc: Is Infosys Ltd. worth buying?
Item: Immunovant Inc
Rating: 1.29241675
Author: Trendlyne DVM scores

about

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to addr...

16.10 -0.29 (-1.77%)

53.29% Fall from 52W High

2.8M

XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.2 / 100

Technically Neutral

46.5 / 100

No estimates available

Immunovant Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Immunovant Inc Live Share Price Today, Share Analysis and Chart

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to addr...

53.29% Fall from 52W High

SWOT Analysis

Immunovant Inc Live Price Chart

Immunovant Inc FAQ

How is Immunovant Inc today?

Immunovant Inc today is trading in the red, and is down by -1.77% at 16.10.

How has Immunovant Inc performed historically?

Immunovant Inc is currently trading down -1.77% on an intraday basis. In the past week the stock rose 1.51%. stock has been down -10.01% in the past quarter and fell -38.22% in the past year. You can view this in the overview section.